Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 12 studies | 91% ± 12% | |
type I pneumocyte | 10 studies | 56% ± 25% | |
endothelial cell of lymphatic vessel | 7 studies | 52% ± 25% | |
fibroblast | 7 studies | 46% ± 30% | |
T cell | 5 studies | 59% ± 32% | |
dendritic cell | 5 studies | 45% ± 14% | |
mast cell | 5 studies | 37% ± 26% | |
natural killer cell | 5 studies | 52% ± 22% | |
pericyte | 5 studies | 42% ± 29% | |
smooth muscle cell | 5 studies | 43% ± 27% | |
capillary endothelial cell | 5 studies | 33% ± 16% | |
B cell | 4 studies | 45% ± 25% | |
alveolar macrophage | 4 studies | 49% ± 16% | |
macrophage | 4 studies | 52% ± 18% | |
club cell | 4 studies | 58% ± 28% | |
monocyte | 3 studies | 77% ± 18% | |
plasma cell | 3 studies | 47% ± 16% | |
CD4-positive, alpha-beta T cell | 3 studies | 28% ± 6% | |
adventitial cell | 3 studies | 25% ± 5% | |
endothelial cell of artery | 3 studies | 35% ± 3% | |
myofibroblast cell | 3 studies | 35% ± 19% | |
vein endothelial cell | 3 studies | 26% ± 0% | |
ciliated cell | 3 studies | 70% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 8 studies | 52% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 308719.11 | 577 / 578 | 61% | 615.01 | 710 / 1155 |
brain | 100% | 345.77 | 2638 / 2642 | 26% | 1.38 | 181 / 705 |
thymus | 96% | 225.56 | 628 / 653 | 10% | 4.93 | 63 / 605 |
eye | 0% | 0 | 0 / 0 | 96% | 10.30 | 77 / 80 |
skin | 62% | 93.84 | 1116 / 1809 | 24% | 5.75 | 113 / 472 |
heart | 36% | 55.52 | 312 / 861 | 0% | 0 | 0 / 0 |
esophagus | 31% | 33.79 | 449 / 1445 | 1% | 6.88 | 2 / 183 |
adrenal gland | 28% | 39.44 | 72 / 258 | 3% | 0.13 | 8 / 230 |
peripheral blood | 28% | 67.97 | 263 / 929 | 0% | 0 | 0 / 0 |
prostate | 28% | 26.92 | 69 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 28% | 86.68 | 374 / 1335 | 0% | 0 | 0 / 0 |
stomach | 25% | 22.62 | 90 / 359 | 1% | 0.05 | 2 / 286 |
uterus | 24% | 16.82 | 41 / 170 | 0% | 0.02 | 2 / 459 |
intestine | 24% | 41.16 | 229 / 966 | 1% | 0.81 | 4 / 527 |
muscle | 24% | 33.22 | 195 / 803 | 0% | 0 | 0 / 0 |
breast | 23% | 26.54 | 107 / 459 | 0% | 0.04 | 2 / 1118 |
adipose | 23% | 55.66 | 277 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 22% | 22.22 | 71 / 328 | 1% | 0.02 | 1 / 178 |
liver | 21% | 41.12 | 48 / 226 | 0% | 0.01 | 1 / 406 |
kidney | 20% | 19.90 | 18 / 89 | 1% | 0.06 | 7 / 901 |
ovary | 17% | 472.08 | 31 / 180 | 0% | 0 | 0 / 430 |
spleen | 15% | 15.55 | 35 / 241 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 6% | 59.18 | 30 / 504 |
tonsil | 0% | 0 | 0 / 0 | 4% | 2.26 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
GO_0097486 | Cellular component | multivesicular body lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0097208 | Cellular component | alveolar lamellar body |
GO_0005576 | Cellular component | extracellular region |
GO_0042599 | Cellular component | lamellar body |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SFTPC |
Protein name | Pulmonary surfactant-associated protein C (Pulmonary surfactant-associated proteolipid SPL(Val)) Pulmonary surfactant-associated protein C (SP-C) (Pulmonary surfactant-associated proteolipid SPL(Val)) (SP5) Pulmonary surfactant-associated protein C |
Synonyms | SFTP2 |
Description | FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . FUNCTION: Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. . |
Accessions | C9JYF6 ENST00000318561.7 [P11686-1] ENST00000524255.5 ENST00000679463.1 [P11686-2] ENST00000521315.5 [P11686-2] ENST00000520605.5 E5RG20 E5RI64 ENST00000522109.5 E5RHW5 P11686 A0A0S2Z4Q0 ENST00000523296.1 ENST00000437090.6 E5RI92 |